Rebuilding a whole heart for children born with only half of one
Using a combination of surgical procedures developed over the last 11 years, surgeons at Boston Children's Hospital have established a new approach for rebuilding the heart in children born with a severe heart defect called hypoplastic left heart syndrome (HLHS). This "staged left ventricle recruitment" (SLVR) strategy uses the existing standard single-ventricle treatment for HLHS and additional procedures to spur the body's capacity for healing and growth and encourage the small left ventricle in these children to grow and function.
Members of Boston Children's Departments of Cardiac Surgery and Cardiology—including Sitaram M. Emani, MD; Wayne Tworetzky, MD; James E. Lock, MD; and Pedro J. del Nido, MD—reported their results to date with the SLVR strategy in the November 6 issue of the Journal of the American College of Cardiology.
HLHS is a rare but severe congenital heart defect in which the left ventricle, the chamber of the heart that pumps blood out into the body, does not develop properly. The majority of children born with HLHS undergo a series of three procedures, together known as single ventricle palliation (SVP), culminating in the Fontan procedure. Surgeons use the sequence to reconstruct a child's heart so that it can function with only a single working ventricle, but only about half of patients treated in this way survive to adulthood.
"Many of the children who reach adulthood eventually require a heart transplant because their Fontan circulation doesn't work effectively or causes additional complications," according to Emani, a pediatric cardiac surgeon who specializes in cardiovascular surgery for newborns and children with complex congenital heart disease.
In 2001, del Nido, Emani and their colleagues started considering ways to help children with HLHS avoid SVP as an end goal and improve long-term outcomes by reconstructing the heart so that it has two working ventricles.
"Children have an enormous growth and healing potential," Emani explained. "We realized that rather than give up on the left ventricle and commit a child to single ventricle circulation for life, we could leverage that growth potential in a staged approach that would promote growth in the left ventricle and gradually recruit it back into operation."
With the SLVR approach, a child undergoes initial single ventricle palliation with the Norwood procedure—a procedure pioneered at Boston Children's in the 1980s—in order to stabilize their circulation. Surgeons then perform additional procedures over time, such as mitral or aortic valve repair, removal of endocardial fibroelastic (EFE) tissue (tough tissue that can restrict the heart's pumping motion) and closure of atrial septal defects (gaps in the wall between the heart's left and right atriums).
Between each procedure, surgeons allow the child's heart to heal and strengthen, setting the stage for the next operation.
"The goal is to promote blood flow through the patient's left ventricle and thereby stimulate growth of the ventricle," Emani said. "If we can do that, we give the ventricle an opportunity to function."
Emani noted that the SLVR approach is highly customizable based on each individual child's unique heart anatomy. It also requires a high degree of collaboration and an open approach to cardiac care involving multiple medical and surgical subspecialties.
In their report, the authors document their experiences developing and refining the SLVR approach between 2001 and 2010. In that time, 34 children were treated using the approach, 12 of whom were successfully converted to complete, two-ventricle circulation. In the short term, survival rates among SLVR-treated patients have been slightly better than a comparable group of children who underwent SVP.
In addition, patients who underwent SLVR also displayed significant growth in the valves and chambers on the left side of the heart, even if surgeons could not get the left ventricle to function completely, demonstrating that the strategy can effectively rehabilitate the heart and successfully support its growth and function.
Compared to SVP, the SLVR approach has had equal if not better outcomes over the last decade. The approach's overall benefits are geared toward improved long-term outcomes and survival into adulthood.
The team notes that in the short term the SLVR approach is more invasive and intensive than the single ventricle approach. But they expect that the long-term benefits of SLVR—especially in terms of reduced risks of future hospitalization, surgery and heart transplantation—will far outweigh the initial costs.
"We believe the SLVR strategy could revolutionize the pediatric cardiology field's approach to treatment of HLHS," Emani says. "The general consensus has been that conversion to single ventricle circulation is the safest approach, but it has significant limitations when it comes to adult survival. While we are still refining the process, we think our two-ventricle approach will help children with HLHS not just survive but thrive into adulthood."
Journal reference: Journal of the American College of Cardiology
Provided by Children's Hospital Boston
- Surgeons pilot expandable prosthetic valves for congenital heart disease Oct 03, 2012 | not rated yet | 0
- In infant heart surgery, newer technique yields better survival in first year of life May 26, 2010 | not rated yet | 0
- Erectile dysfunction drug may benefit cardiac function in young patients with heart defects May 08, 2012 | not rated yet | 0
- In a challenging infant heart defect, two-thirds may have high chance of survival Oct 26, 2010 | not rated yet | 0
- Drug for erectile dysfunction improves heart function in young heart-disease patients Nov 18, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
The Durability of Bone: Long Falls
5 hours ago I am doing a paper on the physics in Valve's Portal and got interested in the "Long Fall Boots" that prevent any damage no matter how far you fall. I...
Is energy convertible to matter?
6 hours ago Can we convert energy to matter?
Rotating electron as a dipole is this right?
9 hours ago An electron as shown by the Stern Gerlach experiment behaves like a dipole (albeit only in one of two states). I have been trying to figure out how...
Dipole term in multipole expansion
13 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
14 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
May 21, 2013 Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
- More from Physics Forums - Classical Physics
More news stories
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology 9 hours ago | 5 / 5 (1) | 0
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology 10 hours ago | not rated yet | 0
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology 11 hours ago | 5 / 5 (1) | 0 |
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology 19 hours ago | 5 / 5 (1) | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
16 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
13 hours ago | 4.9 / 5 (11) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
15 hours ago | 4.6 / 5 (7) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
9 hours ago | 3.7 / 5 (3) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
10 hours ago | 5 / 5 (4) | 0 |
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
13 hours ago | 5 / 5 (6) | 0 |